Seeing Red: Clinical Assessment Tools for Clinical Trial Decision Support

Launched by SCOTIADERM · Feb 26, 2023

Keywords

ClinConnect Summary

This clinical trial, titled "Seeing Red," is focused on improving how nurses document and assess certain skin conditions caused by moisture, specifically incontinence-associated dermatitis (IAD) and intertrigo (ITD). These conditions can lead to rashes and skin damage, and the study aims to test a new structured tool that helps nurses describe and track these skin issues more accurately. By using a standardized approach, the trial hopes to make it easier to monitor how these rashes develop and respond to treatment, ensuring that all nurses assess the conditions in a consistent way.

To participate in this study, you need to be at least 18 years old and diagnosed with either IAD or ITD, with an expected hospital stay of at least seven days. You'll be asked to provide consent for daily photographs of your rash to help with tracking its healing. Participants can expect to be part of a process that not only enhances their care but also contributes to better nursing practices in the future. The trial is not yet recruiting participants, so it's still in the early stages of planning.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • age ≥ 18 years
• • Intertrigo (ITD) and or incontinence-associated dermatitis (IAD)
• • Expected length of stay of seven (7) days
• • life expectancy greater than one week
• • written informed consent by the patient or his/her representative including explicit consent to take daily photographs of the rash associated with MASD.
• Exclusion Criteria:
• • known allergy to standard MASD treatments
• • life expectancy less than seven days
• • complex skin disorders